RxDoctor Payments Data

Stephanie Bridges

Family · Winter Haven, FLNPI 1184962441

Payments from drug & device makers

$9,139in general payments, 2019–2025

Across 522 payments — averaging $17.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Pfizer$690
  • Boehringer Ingelheim$651
  • Amgen$610
  • AbbVie$603
  • GSK$603
  • plus $5K from 40 others

What the payments were for

  • Food & beverage$9,105100%
  • Education$340%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,139 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$13,250
Medicare patients
117
Services billed
899

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban54$53,810
FarxigaDapagliflozin Propanediol29$33,125
OzempicSemaglutide30$31,739
XareltoRivaroxaban19$27,362
JardianceEmpagliflozin21$20,879
TrulicityDulaglutide18$20,748
MounjaroTirzepatide15$15,184
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$12,999
Repatha SureclickEvolocumab15$11,464
Spiriva RespimatTiotropium Bromide13$9,834
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$8,087
Atorvastatin Calcium389$2,872
Rosuvastatin Calcium229$2,165
Levothyroxine Sodium181$2,105
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$2,094

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$690$53,81054 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,117$46,12441 claims
Lilly USA, LLCTrulicity, Mounjaro$224$35,93233 claims
Novo NordiskOzempic$376$31,73930 claims
Boehringer IngelheimJardiance, Spiriva Respimat$651$30,71434 claims
Johnson & JohnsonXarelto$136$27,36219 claims
GSKTrelegy Ellipta$603$8,08711 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$13$2,105181 claims
AbbVieSynthroid$603$71615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 14,618 family providers in Florida.

Other family in Winter Haven

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →